04/10/2019
3:34 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
04/02/2019
3:15 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2019
2:17 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2019
1:50 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
03/01/2019
3:43 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2019
6:26 AM | Concert Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2019
6:22 AM | Concert Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2019
6:08 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2019
4:17 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G
| |
02/07/2019
4:11 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/07/2019
3:35 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2019
7:46 AM | Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A
| |
01/08/2019
3:10 PM | Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:09 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:08 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:07 PM | Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2019
3:06 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2018
5:56 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2018
3:08 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2018
3:00 PM | Concert Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G
| |
11/19/2018
4:27 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2018
4:22 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2018
4:21 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
6:33 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2018
6:28 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2018
6:30 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2018
6:27 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2018
3:04 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
6:01 PM | Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
6:00 PM | Concert Pharmaceuticals (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:59 PM | Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:58 PM | Concert Pharmaceuticals (Issuer)
Fitzgerald Meghan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:57 PM | Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:57 PM | Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:56 PM | Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
5:55 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2018
3:05 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2018
3:56 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2018
6:37 AM | Concert Pharmaceuticals (Filer)
| Form DEF 14A
| |
05/03/2018
6:33 AM | Concert Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2018
6:30 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2018
3:07 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2018
3:51 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4/A
| |
04/13/2018
3:50 PM | Concert Pharmaceuticals (Issuer)
HERSCHA LYNETTE (Reporting)
| Form 4/A
| |
04/13/2018
3:47 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4/A
| |
04/13/2018
3:46 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4/A
| |
04/10/2018
7:00 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2018
3:22 PM | Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2018
3:21 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2018
3:20 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2018
3:19 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2018
3:06 PM | Concert Pharmaceuticals (Filed by)
Processa Pharmaceuticals, Inc. (Subject)
| Form SC 13G
| |
03/07/2018
11:15 PM | Concert Pharmaceuticals (Filer)
| Form EFFECT
| |
03/05/2018
3:29 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2018
6:41 AM | Concert Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/01/2018
6:38 AM | Concert Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/01/2018
6:34 AM | Concert Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2018
6:31 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
1:33 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2018
3:35 PM | Concert Pharmaceuticals (Subject)
GLAXOSMITHKLINE PLC (Filed by)
| Form SC 13G/A
| |
02/09/2018
4:12 PM | Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G
| |
02/05/2018
3:20 PM | Concert Pharmaceuticals (Subject)
TVM Life Science Ventures VI GmbH & Co KG (Filed by)
| Form SC 13G/A
| |
02/01/2018
3:36 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2018
8:26 AM | BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
| Form SC 13G
| |
01/29/2018
4:43 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2018
3:20 PM | Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4/A
| |
01/26/2018
3:19 PM | Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 3/A
| |
01/24/2018
3:43 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2018
3:34 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2018
3:26 PM | ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:52 PM | Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:39 PM | Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:36 PM | Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:34 PM | Concert Pharmaceuticals (Issuer)
HERSCHA LYNETTE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:30 PM | Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:23 PM | BECKER MARC (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2018
5:21 PM | BECKER MARC (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2017
3:29 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2017
3:29 PM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2017
6:40 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2017
6:30 AM | Concert Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2017
3:48 PM | Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
